Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Psychopharmacology Bulletin VOL 36 Supplement No. 2 - Full Issue Stacked PDF
1
x
$
60.00
Jefferson B. Prince, MD: Citalopram for the Treatment of Adolescent Anxiety Disorders: A Pilot Study
1
x
$
30.00
Revisiting Lithium: Utility for Behavioral Stabilization in Adolescents and Adults with Autism Spectrum Disorder
1
x
$
30.00
Unraveling the Diagnostic Clues of Depression and GAD: The Primary Care Challenge
1
x
$
30.00
VOL 4 No. 2 Full Issue - February 2002
1
x
$
20.00
Enfoque clínico: Componentes cognitivos y biológicos que participan en el desarrollo del trastorno por estrés postraumático
1
x
$
0.00
Vicki L. Ellingrod, PharmD, BCPP: 5-HT2A Receptor Promoter Polymorphism, -1438G/A and Negative Symptom Response to Olanzapine in Schizophrenia
1
x
$
30.00
VOL 3 No. 8 Full Issue - August 2001
1
x
$
20.00
Top-Up Clozapine for Risperidone LAI-Related Acute Dystonia and TR Bipolar in an Adolescent with ID-Putting the Cart before the Horse?
1
x
$
30.00
Letter From the Editors: Addressing the Quality Chasm for a New Health System in the 21st Century
1
x
$
0.00
The Effectiveness of Long-Acting Injectable Risperidone in a Population of Psychiatric Out-Patients: 1-Year Naturalistic Study
1
x
$
30.00
Aysegul Yolga Tahiroglu, MD: Polypharmacy and EPS in a Child; A Case Report
1
x
$
30.00
R. Bart Sangal, MD: What Is a Significant Response in Drug Studies of Attention- Deficit/Hyperactivity Disorder: Statistical Significance Is Necessary, But Is It Sufficient?
1
x
$
30.00
View Cart
Checkout
Home
Store
“R. Bart Sangal, MD: What Is a Significant Response in Drug Studies of Attention- Deficit/Hyperactivity Disorder: Statistical Significance Is Necessary, But Is It Sufficient?” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Obesogenic Medications and Weight Gain Over 24 Weeks in Patients with Depression: Results from the GUIDED Study
$
30.00
Add to cart
Details
MDMA to Treat PTSD in Adults
$
30.00
Add to cart
Details
Developing an IV Ketamine Clinic for Treatment-Resistant Depression: a Primer
$
30.00
Add to cart
Details
Consistently Modest Antidepressant Effects in Clinical Trials: the Role of Regulatory Requirements (OPEN ACCESS)
$
0.00
Add to cart
Details
Struggling to find Effective Pharmacologic Options for Akathisia? B-CALM!
$
30.00
Add to cart
Details
Lithium-Induced Hyperparathyroidism: An Ill-defined Territory (OPEN ACCESS)
$
0.00
Add to cart
Details
Treatment of Insomnia with Zaleplon in HIV+ Significantly Improves Sleep and Depression
$
30.00
Add to cart
Details
The Role of Religiosity and Guilt in Symptomatology and Outcome of Obsessive Compulsive Disorder
$
30.00
Add to cart
Details
Long Acting Injectables and their Correlation with Subjectivity in Schizophrenia Spectrum Disorder
$
30.00
Add to cart
Details
ADHD and Drug Holidays: Effects on Anthropometric Changes during Methylpenidate Treatment
$
30.00
Add to cart
Details
Can a ‘Shot’ Help Prevent Youth Re-Incarceration? Case Report on Use of a Long-Acting Injectable Antipsychotic in Incarcerated Youth (OPEN ACCESS)
$
0.00
Add to cart
Details
Development of a Patient-Centered Software System to Facilitate Effective Management of Bipolar Disorder
$
30.00
Add to cart
Details
Clozapine Prolongs Cortical Silent Period in Patients with Treatment- Resistant Schizophrenia
$
30.00
Add to cart
Details
Impact of the Omics-Based Biomarkers on the Mirtazapine’s Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder
$
30.00
Add to cart
Details
A Phase 3 Placebo-Controlled Trial of Once-Daily 400-mg and 600-mg SPN-812 (Viloxazine Extended- Release) in Adolescents with ADHD (OPEN ACCESS)
$
0.00
Add to cart
Details
Obsessive-Compulsive Disorder Driven by Aspects of Ritual Addiction: A Case Report and Review of Literature
$
30.00
Add to cart
Details
Brexpiprazole for the Treatment of Schizophrenia and Major Depressive Disorder: A Comprehensive Review of Pharmacological Considerations in Clinical Practice
$
30.00
Add to cart
Details
Lamotrigine and Stevens-Johnson Syndrome Prevention
$
30.00
Add to cart
Details
Brexanolone to Treat Postpartum Depression in Adult Women
$
30.00
Add to cart
Details
Hyperprolactinemia, Clinical Considerations, and Infertility in Women on Antipsychotic Medications
$
30.00
Add to cart
Details
Previous
1
…
6
7
8
…
44
Next
Page load link
Go to Top
